about
Assessment of Multifactor Gene-Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors.Vitamin D suppresses leptin stimulation of cancer growth through microRNA.Decreased severity of ovarian cancer and increased survival in hens fed a flaxseed-enriched diet for 1 yearGenome-wide investigation of regional blood-based DNA methylation adjusted for complete blood counts implicates BNC2 in ovarian cancer.Obesity increases tumor aggressiveness in a genetically engineered mouse model of serous ovarian cancer.Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies.Pre- and post-diagnosis body mass index, weight change, and ovarian cancer mortalityUrinary interleukin-1β levels among gynecological patients.HE4 as a biomarker for ovarian and endometrial cancer management.Body size and the risk of ovarian cancer by hormone therapy use in the California Teachers Study cohortThe epidemiology of endometrial and ovarian cancer.Co-occurring obesity and smoking among U.S. women of reproductive age: Associations with educational attainment and health biomarkers and outcomesOvarian cancer and smoking: individual participant meta-analysis including 28,114 women with ovarian cancer from 51 epidemiological studies.Leptin stimulation of cell cycle and inhibition of apoptosis gene and protein expression in OVCAR-3 ovarian cancer cellsRecent Advancements in Prognostic Factors of Epithelial Ovarian Carcinoma.Hormonal risk factors and invasive epithelial ovarian cancer risk by parityThe molecular mechanism of action of superactive human leptin antagonist (SHLA) and quadruple leptin mutein Lan-2 on human ovarian epithelial cell lines.Molecular pathogenesis of endometrial and ovarian cancer.Ovarian cancer risk factors in African-American and white womenEpidemiologic correlates of ovarian cortical inclusion cysts (CICs) support a dual precursor pathway to pelvic epithelial cancer.Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer.HE4 transcription- and splice variants-specific expression in endometrial cancer and correlation with patient survival.The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer.Expression of leptin receptor in endometrial biopsies of endometrial and ovarian cancer patients.Epidemiology of ovarian cancer: a review.Anthropometric factors and ovarian cancer risk: a systematic review and nonlinear dose-response meta-analysis of prospective studies.Superactive human leptin antagonist (SHLA), triple Lan1 and quadruple Lan2 leptin mutein as a promising treatment for human folliculomaCancers attributable to excess body weight in Canada in 2010.Predictive value of serum HE4 and CA125 concentrations for lymphatic metastasis of endometrial cancer.The association between overweight, obesity and ovarian cancer: a meta-analysis.Is race really a negative prognostic factor for cancer?Phenformin has anti-tumorigenic effects in human ovarian cancer cells and in an orthotopic mouse model of serous ovarian cancer.Quantitative proteomic analysis of murine white adipose tissue for peritoneal cancer metastasis.Increased efficacy of metformin corresponds to differential metabolic effects in the ovarian tumors from obese versus lean mice.Adiponectin Reverses the Proliferative Effects of Estradiol and IGF-1 in Human Epithelial Ovarian Cancer Cells by Downregulating the Expression of Their Receptors.Visceral abdominal fat measured by computer tomography as a prognostic factor for gynecological malignancies?Identifying the Causes of Cancer Health Disparities: Biologic and Non Biologic Determinants.Body mass index and cancer incidence: the FINRISK study
P2860
Q30277151-C0D3B82B-CB3A-4932-B8BD-FD8FC1A38BA6Q30367127-B75F497B-0429-4BA0-B526-5AD0636F0273Q33770929-FCEA091F-ECC3-453C-B475-8757BFEDE9E8Q33810288-86EDC224-C36A-492A-9813-97454516B14EQ33877598-F74D6618-5F59-4DB8-B69F-E6E5F545A322Q34273433-1E1C8F81-CBFC-4B4D-BD25-D674D1240045Q34555347-C9C7AC76-A572-43E1-A207-653315A5429FQ34584672-0E8F06B3-5D78-4B27-8B37-8AA71E2D7CF5Q34611530-730BB103-9AFC-4B39-8193-19E91D23C87AQ35059760-9F6D309C-2FE6-4499-9795-B4658C20F916Q35676052-A493C8EC-DA7D-42C5-BAD6-5B1EB79D4287Q36117652-C1505BBB-A141-4B8A-8FCF-2154F3C5BED4Q36201263-8433D215-42B4-476F-AAC8-3C41A6F6A970Q36670639-F83316DF-C41B-442F-BE3B-47444405967BQ36979335-B40FAF72-4568-49C6-A563-069A193B6879Q37081955-CEBE348E-76AB-486F-A337-E555F045FB09Q37230628-D1340E3D-618C-42D6-98E3-8671B21DC2A4Q37293672-509772CD-656D-443A-9601-A9D992ECD69AQ37321558-223D8163-9826-4866-B467-2EA37AFC8DB5Q37335987-92E5EB2D-482C-4950-98A2-4A0295752A38Q37370000-D699CBDD-378A-4F9A-9EBE-7B4ABB44E2BCQ37375504-4DC0F55F-5BCC-4347-B13D-86DB1DA9C685Q37457596-07795B12-92A6-4BDC-901F-BEFD4446AC37Q37566675-3CD9A394-54B0-41DC-A26B-350EA3BCF100Q37720438-70ED1848-F67E-4646-B667-8A8197B1300EQ38253766-D97CCDC2-811F-4315-897F-91F867AA6BB5Q38598392-A97C5B6A-85E7-4F40-BDA2-E1FCE68B4790Q38658268-A3D93364-4E81-4572-8FE8-037EDE98C866Q39014460-17F50C88-BA4B-444A-A7CA-45CE2A1141D3Q41194694-81435E58-E41A-43E6-8168-CD5318C8B489Q44975348-6E382D82-8EDA-4CEE-B268-2369FCEB2037Q47098834-DC9C5D01-2006-48E4-B73A-60A84FF8ECDBQ47241195-B7464F36-7F94-4515-94BA-B812C06CAAF8Q49194546-099F99CC-FC5C-4021-AC84-34115B857C21Q55023785-4A87D59B-8AC9-45A5-AAF1-41E0BCEFD8A7Q55386905-7EE27AA5-B7B4-4063-BA82-E980B9D6B59FQ55401345-CAC39F87-C0A1-4A37-A2BF-048324039C18Q57303248-54077A0D-A49F-4F09-97B8-DCD588C4C762
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Body mass index and risk of ovarian cancer.
@ast
Body mass index and risk of ovarian cancer.
@en
type
label
Body mass index and risk of ovarian cancer.
@ast
Body mass index and risk of ovarian cancer.
@en
prefLabel
Body mass index and risk of ovarian cancer.
@ast
Body mass index and risk of ovarian cancer.
@en
P2093
P2860
P50
P356
P1433
P1476
Body mass index and risk of ovarian cancer.
@en
P2093
Albert R Hollenbeck
Corinna Koebnick
James V Lacey
Kim N Danforth
Steven C Moore
P2860
P304
P356
10.1002/CNCR.24086
P407
P577
2009-02-01T00:00:00Z